New Drug Rusfertide Shows Promise in Treating Polycythemia Vera, Revealing Positive Outcomes
Polycythemia vera falls under the category of chronic myeloproliferative neoplasms, which disrupt the normal production of blood cells within the bone marrow.
Source: techtimes.com